These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8797578)

  • 1. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.
    Taniguchi K; Wada M; Kohno K; Nakamura T; Kawabe T; Kawakami M; Kagotani K; Okumura K; Akiyama S; Kuwano M
    Cancer Res; 1996 Sep; 56(18):4124-9. PubMed ID: 8797578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
    Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
    Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter.
    Lee K; Belinsky MG; Bell DW; Testa JR; Kruh GD
    Cancer Res; 1998 Jul; 58(13):2741-7. PubMed ID: 9661885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
    Narasaki F; Oka M; Nakano R; Ikeda K; Fukuda M; Nakamura T; Soda H; Nakagawa M; Kuwano M; Kohno S
    Biochem Biophys Res Commun; 1997 Nov; 240(3):606-11. PubMed ID: 9398612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport.
    Uchiumi T; Hinoshita E; Haga S; Nakamura T; Tanaka T; Toh S; Furukawa M; Kawabe T; Wada M; Kagotani K; Okumura K; Kohno K; Akiyama S; Kuwano M
    Biochem Biophys Res Commun; 1998 Nov; 252(1):103-10. PubMed ID: 9813153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.
    Paulusma CC; van Geer MA; Evers R; Heijn M; Ottenhoff R; Borst P; Oude Elferink RP
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assignment of the canalicular multispecific organic anion transporter gene (CMOAT) to human chromosome 10q24 and mouse chromosome 19D2 by fluorescent in situ hybridization.
    van Kuijck MA; Kool M; Merkx GF; Geurts van Kessel A; Bindels RJ; Deen PM; van Os CH
    Cytogenet Cell Genet; 1997; 77(3-4):285-7. PubMed ID: 9284939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome.
    Paulusma CC; Kool M; Bosma PJ; Scheffer GL; ter Borg F; Scheper RJ; Tytgat GN; Borst P; Baas F; Oude Elferink RP
    Hepatology; 1997 Jun; 25(6):1539-42. PubMed ID: 9185779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver.
    Wielandt AM; Vollrath V; Manzano M; Miranda S; Accatino L; Chianale J
    Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):105-11. PubMed ID: 10377250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2).
    Kawabe T; Chen ZS; Wada M; Uchiumi T; Ono M; Akiyama S; Kuwano M
    FEBS Lett; 1999 Aug; 456(2):327-31. PubMed ID: 10456333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome.
    Kajihara S; Hisatomi A; Mizuta T; Hara T; Ozaki I; Wada I; Yamamoto K
    Biochem Biophys Res Commun; 1998 Dec; 253(2):454-7. PubMed ID: 9878557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
    An G; Ng AY; Meka CS; Luo G; Bright SP; Cazares L; Wright GL; Veltri RW
    Cancer Res; 2000 Dec; 60(24):7014-20. PubMed ID: 11156405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
    Nagatani G; Nomoto M; Takano H; Ise T; Kato K; Imamura T; Izumi H; Makishima K; Kohno K
    Cancer Res; 2001 Feb; 61(4):1592-7. PubMed ID: 11245470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel human amino acid transporter, hNAT3: cDNA cloning, chromosomal mapping, genomic structure, expression, and functional characterization.
    Gu S; Adan-Rice D; Leach RJ; Jiang JX
    Genomics; 2001 Jun; 74(3):262-72. PubMed ID: 11414754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.
    Bell SM; Shaw M; Jou YS; Myers RM; Knowles MA
    Genomics; 1997 Sep; 44(2):163-70. PubMed ID: 9299232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.
    Chen ZS; Kawabe T; Ono M; Aoki S; Sumizawa T; Furukawa T; Uchiumi T; Wada M; Kuwano M; Akiyama SI
    Mol Pharmacol; 1999 Dec; 56(6):1219-28. PubMed ID: 10570049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.
    Shen DW; Goldenberg S; Pastan I; Gottesman MM
    J Cell Physiol; 2000 Apr; 183(1):108-16. PubMed ID: 10699972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins.
    Belinsky MG; Bain LJ; Balsara BB; Testa JR; Kruh GD
    J Natl Cancer Inst; 1998 Nov; 90(22):1735-41. PubMed ID: 9827529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of organic anion transport in the liver.
    Roelofsen H; Müller M; Jansen PL
    Yale J Biol Med; 1997; 70(4):435-45. PubMed ID: 9626764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
    Shen D; Pastan I; Gottesman MM
    Cancer Res; 1998 Jan; 58(2):268-75. PubMed ID: 9443404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.